# Oral Bioavailability,and Food Effect Study and Single Ascending Dose PK Study in Healthy Male Volunteers

> **NCT03372239** · PHASE1 · COMPLETED · sponsor: **NewLink Genetics Corporation** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Indoximod base formulation
- **DRUG:** Indoximod HCL (salt) formulation
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03372239
- **Lead sponsor:** NewLink Genetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-21
- **Primary completion:** 2018-01-25
- **Final completion:** 2018-04-16
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03372239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03372239, "Oral Bioavailability,and Food Effect Study and Single Ascending Dose PK Study in Healthy Male Volunteers". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT03372239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*